Dementia and Alzheimer Disease

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Dr. Bobby Lazzara reports on a clinical trial of aducanumab, a human monoclonal antibody, in patients with prodromal or mild Alzheimer disease.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

Why is a lower BMI linked to greater dementia risks in the elderly? Dr. Bobby Lazzara discusses a recent analysis using the Harvard Aging Brain Study.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.

Dr. Bobby Lazzara discusses the first description of reversal of cognitive decline in early Alzheimer disease or its precursors.

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

In this Medical News Minute, Dr. Bobby Lazzara discusses a recent finding on Alzheimer disease and chromosome Y in men.

Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

Neuropsychiatric symptoms are commonly associated with mild cognitive impairment, but does amyloid pathology play a role in this relationship?

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

Our Jan. news & research list includes the possible lingering effects of childhood concussion and the benefits of vitamin D for MS.

New findings regarding viruses and neuronal cells could provide clues for possible new therapies for MS and Alzheimer disease.

Compliance, an obstacle in depression treatment for all patients, can be especially difficult for patients with dementia.

Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.

A groundbreaking discovery may lead to repair of neurodegenerative diseases such as Alzheimer and Parkinson.

The holidays can be an especially stressful time of year, so patients need to be aware of how stress influences neurological disease progression.

Our Nov. news & research list includes 2 successful genetic Alzheimer treatments in mouse models and a potential drug for Parkinson disease psychosis.

Research findings indicate that signs of Alzheimer may begin earlier than previously thought and genotyping could identify those at risk.

Researchers studied type 2 diabetes-induced neurodegeneration and the possible link to Alzheimer disease.

Researchers found associations between cognitive test scores and eventual Alzheimer disease.

Studies of a kuru epidemic in a formerly cannibalistic tribe could lead to further understanding of other neurodegenerative diseases, such as Alzheimer and Parkinson.

Neurologists will need to improve documentation for several common diagnoses to make a successful ICD-10 transition. Here are six helpful tips.